The liver is the initial target of orally administered sex steroids. Most of the effects of sex hormones on the liver are mediated through changes in the expression of specific genes. The major objective of this proposal is to explore cellular and molecular aspects of the androgenic regulation of alpha2u globulin gene expression in the liver, especially in the context of changing hormone responsiveness during maturation and aging. In the normal male rat, hepatic synthesis of alpha(2u) globulin and its mRNA begins at the onset of puberty (about 40 days) and ceases at senescence (about 800 days). Such age-dependent regulation of alpha(2u) globulin gene expression correlates with the temporal changes in hepatic androgen sensitivity that are associated with the appearance/disappearance of a 31 kDa cytoplasmic androgen binding (GAB) protein. A disjunction of hepatic androgen sensitivity and alpha(2u) globulin is observed in a mutant strain of rat (NIH Black rat). In this strain, alpha(2u) globulin is not induced by the androgen, despite the appearance of normal hepatic androgen sensitivity during puberty. We plan to utilize the NB rat model to obtain relevant mechanistic information concerning the androgenic regulation of this protein. Other areas of hormonal regulation of alpha(2u) globulin synthesis which will be explored include (I) examination of interaction between the cis- and trans-acting regulatory factors that are involved in the hormone- and age-dependent expression of the alpha(2u) globulin gene family. (II) establishment of the structure-function relationship of the cytoplasmic androgen-binding protein through molecular cloning and sequencing of both the cDNA and the purified protein, and (III) development of an in vitro model for studying the role of tissue architechture and cell-to-cell communication in the initiation and maintenance of hormone action. Results of these studies are expected to provide a deeper insight into the cellular and molecular aspects of steroid hormone action in the liver with important implications in the management of endocrine disorders associated with androgen action.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37DK014744-20
Application #
3483072
Study Section
Endocrinology Study Section (END)
Project Start
1988-02-01
Project End
1994-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
20
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Tyagi, R K; Lavrovsky, Y; Ahn, S C et al. (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14:1162-74
Lavrovsky, Y; Chatterjee, B; Clark, R A et al. (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35:521-32
Song, C S; Jung, M H; Supakar, P C et al. (1999) Negative regulation of the androgen receptor gene promoter by NFI and an adjacently located multiprotein-binding site. Mol Endocrinol 13:1487-96
Roy, A K; Lavrovsky, Y; Song, C S et al. (1999) Regulation of androgen action. Vitam Horm 55:309-52
Lavrovsky, Y; Song, C S; Chatterjee, B et al. (1998) A rapid and reliable PCR-based assay for gene transmission and sex determination in newborn transgenic mice. Transgenic Res 7:319-20
Chan, J; Song, C S; Matusik, R J et al. (1998) Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells. Chem Biol Interact 109:267-78
Chen, S; Song, C S; Lavrovsky, Y et al. (1998) Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Mol Endocrinol 12:1558-66
Chen, S; Supakar, P C; Vellanoweth, R L et al. (1997) Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein. Mol Endocrinol 11:3-15
Roy, A K (1997) Transcription factors and aging. Mol Med 3:496-504
Chatterjee, B; Song, C S; Jung, M H et al. (1996) Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice. Proc Natl Acad Sci U S A 93:728-33

Showing the most recent 10 out of 39 publications